| Symbol |
Name |
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
BTLA
|
B and T lymphocyte associated
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CD24
|
CD24 molecule
|
|
CD247
|
CD247 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD5
|
CD5 molecule
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CSK
|
c-src tyrosine kinase
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
HHLA2
|
HERV-H LTR-associating 2
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1
|
|
MLST8
|
MTOR associated protein, LST8 homolog (S. cerevisiae)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
TMIGD2
|
transmembrane and immunoglobulin domain containing 2
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
